Nikki Cheng

Breast cancer is the most common form of cancer diagnosed in women, with over 1.3 million new cases diagnosed annually in the world. Despite advances in treatment, disease recurrence remains high, up to 56% for patients diagnosed with stage III breast cancer. Metastatic occurrence often accompanies disease relapse, contributing to an 80% mortality rate, and

Research

Overview

Breast cancer is the most common form of cancer diagnosed in women, with over 1.3 million new cases diagnosed annually in the world. Despite advances in treatment, disease recurrence remains high, up to 56% for patients diagnosed with stage III breast cancer. Metastatic occurrence often accompanies disease relapse, contributing to an 80% mortality rate, and estimated 450,000 deaths worldwide. Treatment of breast cancer is complicated by the presence of different molecular subtypes including Luminal A, Luminal B, Her2 overexpressing (Her2+) and Basal-like breast cancers. The mechanisms that regulate progression of these breast cancer subtypes still remain poorly understood. The long-term goals of our research program are to understand the role of and mechanisms of inflammation in early and late stage breast cancer progression, and identify new biomarkers to prevent or treat invasive breast cancer.

Recent Publications
Gage Brummer, Wei Fang, Curtis Smart, Brandon Zinda, Nadia Alissa, Cory Berkland, David Miller, Nikki Cheng, CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments. 2020 Mar;39(11):2275-2289. doi: 10.1038/s41388-019-1141-7. Epub 2019 Dec 11. PMC7071973.

Qingting Hu, Megan Meyers, Wei Fang, Min Yao, Gage Brummer, Justin Hawj, Nikki Cheng. Role of ALDH1A1 and HTRA2 expression in CCL2/CCR2-mediated breast cancer cell growth and invasion. Biol Open. 2019 Jun 28;8(7) DOI:10.1242/bio.040873 PMC6679398

Min Yao, Wei Fang, Curtis Smart, Qingting Hu, Shixia Huang, Nehemiah Alvarez, Patrick Fields, Nikki Cheng. CCR2 chemokine receptors enhance growth and cell cycle progression of breast cancer cells through SRC and PKC activation. Molecular Cancer Research, DOI: 10.1158/1541-7786.MCR-18-0750 Published OnlineFirst. November 16, 2018. PMC6359961

Jacob New,Vikalp Vishwakarma, Dhruv Kumar, Vusala Snyder,.Levi Arnold, Emily Nissen; Qinting Hu; Nikki Cheng, David Miller, Yelizaveta Shnayder,Kiran Kakarala, Terance Tsue, Douglas Girod, Sufi Thomas. Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds. Scientific Reports.2018. 8:12163 | DOI:10.1038/s41598-018-29683-1. PMC6093880

ncG1vNJzZmivp6x7rMHMnGWenKVku6S0xKeeZ6Ckork%3D

 Share!